Intraperitoneal administration of PD-1/PD-L1 inhibitors to mice inhibits fibroblast activation and collagen secretion by fibroblasts, thereby slowing down the progression of lung fibrosis in mice (103). Here, CD274 is linked to pulmonary fibrosis.